12/31/10 - 262,215 - ($17.51) Year-end 2010 close
12/31/11 - 481,195 - ($21.64) Year-end 2011 close
12/31/12 - 701,950 - ($25.08) Year-end 2012 close
01/02 - 738,225 - ($25.91) RSI 63.2, first trading day of the year
01/03 - 737,125 - ($25.85) RSI 61.8, low 2013 stock close and valuation to date
01/29 - 776,115 - ($27.70) RSI 73.4
01/30 - 772,670 - ($27.51) RSI 73.9, ex-dividend 24 cents, sold 70% of Pfizer holdings
02/01 - 773,220 - ($27.63) RSI 71.8, Zoetis IPO
02/07 - 769,115 - ($26.96) RSI 55.7, bought back 1/3 of amount sold on 1/30
02/08 - 767,705 - ($26.88) RSI 54.4
02/15 - 775,195 - ($27.29) RSI 59.8
02/19 - 780,725 - ($27.71) RSI 65.2, high 2013 stock close and valuation to date
02/22 - 776,540 - ($27.38) RSI 58.3
Up 10.6%. 2013 Portfolio gain to date
Up 10.1%. 2013 Pfizer stock price gain to date including one 24-cent dividend
Up 06.3%. S & P 500 gain to date (1,426 to 1,516)
Sentiment: Buy